Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China

被引:0
|
作者
Liu, Yinfeng [1 ]
Zheng, Jie [1 ]
Xu, Yue [2 ]
Lv, Ji [1 ]
Wu, Zizheng [1 ]
Feng, Kai [1 ]
Liu, Jiani [1 ]
Yan, Weitao [1 ]
Wei, Liguang [1 ]
Zhao, Jiangman [2 ]
Jiang, Lisha [2 ]
Han, Meng [1 ]
机构
[1] First Hosp Qinhuangdao, Breast Dis Diag & Treatment Ctr, Qinhuangdao, Hebei, Peoples R China
[2] Shanghai Biotecan Pharmaceut Co Ltd, Shanghai, Peoples R China
关键词
breast cancer; multi-gene panels; rare genetic variants; in silico protein modeling; pathogenic/likely pathogenic variants; GERMLINE MUTATIONS; ASSOCIATION; BRCA1;
D O I
10.3389/fgene.2023.1271710
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Breast cancer, the most prevalent malignancy in women worldwide, presents diverse onset patterns and genetic backgrounds. This study aims to examine the genetic landscape and clinical implications of rare mutations in Chinese breast cancer patients.Methods: Clinical data from 253 patients, including sporadic and familial cases, were analyzed. Comprehensive genomic profiling was performed, categorizing identified rare variants according to the American College of Medical Genetics (ACMG) guidelines. In silico protein modeling was used to analyze potentially pathogenic variants' impact on protein structure and function.Results: We detected 421 rare variants across patients. The most frequently mutated genes were ALK (22.2%), BARD1 (15.6%), and BRCA2 (15.0%). ACMG classification identified 7% of patients harboring Pathogenic/Likely Pathogenic (P/LP) variants, with one case displaying a pathogenic BRCA1 mutation linked to triple-negative breast cancer (TNBC). Also identified were two pathogenic MUTYH variants, previously associated with colon cancer but increasingly implicated in breast cancer. Variants of uncertain significance (VUS) were identified in 112 patients, with PTEN c.C804A showing the highest frequency. The role of these variants in sporadic breast cancer oncogenesis was suggested. In-depth exploration of previously unreported variants led to the identification of three potential pathogenic variants: ATM c.C8573T, MSH3 c.A2723T, and CDKN1C c.C221T. Their predicted impact on protein structure and stability suggests a functional role in cancer development.Conclusion: This study reveals a comprehensive overview of the genetic variants landscape in Chinese breast cancer patients, highlighting the prevalence and potential implications of rare variants. We emphasize the value of comprehensive genomic profiling in breast cancer management and the necessity of continuous research into understanding the functional impacts of these variants.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Genetic testing in patients with pancreatic cancer to reveal pathogenic variants in cancer susceptibility genes
    Tsoulos, Nikolaos
    Potska, Kevisa
    Agiannitopoulos, Konstantinos
    Tsaousis, Georgios
    Ozdogan, Mustafa
    Karabulut, Bulent
    Croitoru, Adina-Emilia
    Ziogas, Dimitrios C.
    Theochari, Maria
    Christodoulou, Christos
    Samantas, Epaminondas
    Janinis, Dimitrios
    Athanasiadis, Ilias
    Koutras, Angelos
    Papadopoulou, Eirini
    Nasioulas, George
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Identification of germline variants in 546 breast/ ovarian cancer families: Complementary testing with multigene NGS and MLPA panels
    Saracoglu, Hilal Piril
    Borklu, Esra
    Altunoglu, Umut
    Selcukbiricik, Fatih
    Erturk, Kayhan
    Vatansever, Dogan
    Celik, Levent
    Lacin, Sahin
    Tunali, Didem
    Avci, Sahin
    Agcaoglu, Orhan
    Karanlik, Hasan
    Atalay, Can
    Kaban, Kerim
    Dilege, Ece
    Taskiran, Cagatay
    Igci, Abdullah
    Mandel, Nil Molinas
    Eraslan, Serpil
    Kayserili, Hulya
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 590 - 590
  • [3] Detection of germline variants in Brazilian breast cancer patients using multigene panel testing
    Cruz Guindalini, Rodrigo Santa
    Viana, Danilo Vilela
    Fumio Whitaker Kitajima, Joao Paulo
    Rocha, Vinicius Marques
    Mendoza Lopez, Rossana Veronica
    Zheng, Yonglan
    Freitas, Erika
    Mendes Monteiro, Fabiola Paoli
    Valim, Andre
    Schlesinger, David
    Kok, Fernando
    Olopade, Olufunmilayo, I
    Azevedo Koike Folgueira, Maria Aparecida
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [4] Detection of germline variants in Brazilian breast cancer patients using multigene panel testing
    Rodrigo Santa Cruz Guindalini
    Danilo Vilela Viana
    João Paulo Fumio Whitaker Kitajima
    Vinícius Marques Rocha
    Rossana Verónica Mendoza López
    Yonglan Zheng
    Érika Freitas
    Fabiola Paoli Mendes Monteiro
    André Valim
    David Schlesinger
    Fernando Kok
    Olufunmilayo I. Olopade
    Maria Aparecida Azevedo Koike Folgueira
    Scientific Reports, 12
  • [5] Determining indications for genetic testing among breast cancer patients with inherited cancer pathogenic/likely pathogenic variants
    Shah, Karina
    Venton, Lindsay
    Tezak, Ann
    Weidner, Anne
    Pal, Tuya
    Reid, Sonya
    GENETICS IN MEDICINE, 2022, 24 (03) : S37 - S37
  • [6] Identification of high and middle penetrance pathogenic variants in patients with hereditary breast/ovarian cancer by multigene panel analysis
    Ryu, Jin-Sun
    Cho, Eun Hae
    Yoon, Kyong-Ah
    Lee, Eun-Gyeong
    Lee, Eun-Sook
    Kong, Sun-Young
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing
    Cummings, Shelly
    Alfonso, Andrew
    Hughes, Elisha
    Kucera, Matt
    Mabey, Brent
    Singh, Nanda
    Eng, Charis
    JCO PRECISION ONCOLOGY, 2023, 7
  • [8] Application of multigene panels in hereditary cancer predisposition testing
    Nikolaev, Sergey
    Danishevich, Anastasia
    Bilyalov, Airat
    Bodunova, Natalia
    Khatkov, Igor
    Gusev, Oleg
    CELL DEATH DISCOVERY, 2022, 8 : 6 - 6
  • [9] Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
    Nguyen-Dumont, Tu
    Dowty, James G.
    MacInnis, Robert J.
    Steen, Jason A.
    Riaz, Moeen
    Dugue, Pierre-Antoine
    Renault, Anne-Laure
    Hammet, Fleur
    Mahmoodi, Maryam
    Theys, Derrick
    Tsimiklis, Helen
    Severi, Gianluca
    Bolton, Damien
    Lacaze, Paul
    Sebra, Robert
    Schadt, Eric
    McNeil, John
    Giles, Graham G.
    Milne, Roger L.
    Southey, Melissa C.
    CANCERS, 2021, 13 (07)
  • [10] Application of Multigene Panels Testing for Hereditary Cancer Syndromes
    Bilyalov, Airat
    Nikolaev, Sergey
    Shigapova, Leila
    Khatkov, Igor
    Danishevich, Anastasia
    Zhukova, Ludmila
    Smolin, Sergei
    Titova, Marina
    Lisica, Tatyana
    Bodunova, Natalia
    Shagimardanova, Elena
    Gusev, Oleg
    BIOLOGY-BASEL, 2022, 11 (10):